Bharatbook.com : Worldwide Pharmacogenomic Market Size By Technology Segments

Pharmacogenomics for Clinical Use and in Drug Development Report( http://www.bharatbook.com/Market-Research-Reports/Pharmacogenomics-for-Clinical-Use-and-in-Drug-Development.html ) provides information on potential benefits in Drug development.

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall. This study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity. Forecasts of the pharmacogenomic market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and the immense possibilities of the future.


The Unrealized Promise of Pharmacogenomics
The New Drug Pipeline
Pharmacogenomics and Regulation
Pharmacogenomics and Reimbursement
Key Considerations for Realizing the Promise of Pharmacogenomics
Development of Easy to Use Point of Care Pharmacogenomic Tests
Development of Pharmacogenomic Tests during Drug Development
Pharmacogenomics' Impact on Commercial Strategies
Pharmacogenomics' Impact on the Blockbuster Model of Drug Development
Pharmacogenomics' Impact on Clinical Trials
Pharmacogenomic Business Models
Structure of Pharmacogenomic Deals and Alliances
Challenges to Pharmacogenomics

For More Information Contact us at:

Bharat Book Bureau
Tel: 91 22 27578668
Fax: 91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com